HLX208

· Shanghai Henlius Biotech

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for HLX208, covering 2022-01-21 to 2023-08-21. Get the full timeline:

Most recent: Clinical Trial Update: The Efficacy and Safety of HLX208 in Advanced Anaplastic Thyroid Cancer (ATC) With BRAF V600 Mutation [Phase 1, Phase 2]

See pricing